Clinical trial
Long-term Follow-up of Glutamic Acid Decarboxylase Gene Transfer to the Subthalamic Nuclei in Participants With Parkinson's Disease
NCT05894343 is registered in ClinicalTrials.gov with MeiraGTx, LLC as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Long-term Follow-up of Glutamic Acid Decarboxylase Gene Transfer to the Subthalamic Nuclei in Participants With Parkinson's Disease
- Lead sponsor
- MeiraGTx, LLC
- Phase
- Phase 1/2
- Overall status
- Active, not recruiting
- Start date
- May 19, 2023
- Completion date
- October 31, 2029
- Enrollment
- 13 (actual)
- Sites
- 6
Conditions
As the registry lists them; a condition with its own page is linked.
parkinson's disease